This inventor holds 5 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Hoechst Marion Roussel Deutschland Gmbh, Sanofi-A Ventis Deutschland Gmbh. Active years: 2000-2006.
Company Filing History:
3 out of 330 
1 out of 18 
1 out of 1,855 
Years Active: 2000-2006
Title: Uwe Westenfelder: A Pioneer in Pharmaceutical Innovations
Introduction
Uwe Westenfelder, an accomplished inventor located in Frankfurt-am-Main, Germany, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of five patents, he has focused on developing innovative methods and compounds aimed at improving treatments for various medical conditions.
Latest Patents
One of Westenfelder's latest advancements involves the crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide. This invention pertains to a specific crystal modification of the compound and details the processes for its preparation and application. The crystal modification is particularly valuable in treating acute immunological episodes such as sepsis, allergies, and autoimmune diseases including rheumatoid arthritis and systemic lupus erythematosus. Furthermore, it has potential therapeutic implications for various cancers, including lung cancer, ovarian cancer, and breast cancer.
Career Highlights
Throughout his career, Uwe Westenfelder has worked with renowned pharmaceutical companies, including Aventis Pharma Deutschland GmbH and Hoechst Marion Roussel Deutschland GmbH. His experiences in these companies have equipped him with in-depth knowledge and skills, fostering innovation in drug development and formulations.
Collaborations
Westenfelder has collaborated with fellow professionals in the field, notably Holger Faasch and Udo Hedtmann. Their combined expertise has likely contributed to the advancement of significant pharmaceutical innovations and refined methodologies in drug formulation.
Conclusion
Uwe Westenfelder exemplifies the spirit of innovation and dedication in the pharmaceutical industry. His contributions through patents targeting critical health issues demonstrate his commitment to improving patient outcomes and advancing medical science. With a solid foundation in research and collaboration, Westenfelder continues to pave the way for future innovations in the field.